Condition: Lumbar Spinal Stenosis · Sponsor: University of Colorado, Denver
Evaluate the benefit of using liposomal bupivicaine in lumbar laminectomies in terms of length of stay, IV narcotic use, 30-day narcotic use, visual analog score (VAS) and 30-day readmissions
This description comes directly from the study's public registry record.
Jens-Peter Witt, MD, PhD · 303-724-2306 · peter.witt@cuanschutz.edu
Akal Sethi, MD · 303-724-1995 · akal.sethi@cuanschutz.edu
Always discuss trial participation with your own doctor first.
| University of Colorado Anschutz Medical Campus | Aurora, Colorado, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04066296